Chromosome 20q Amplification and Kinesin-5 Inhibitor Response
Author Information
Author(s): Jackson Aimee L., Mao Mao, Kobayashi Sumire, Ward Teresa, Biery Matthew, Dai Hongyue, Bartz Steven R., Linsley Peter S.
Primary Institution: Rosetta Inpharmatics LLC
Hypothesis
Can gene expression signatures predict responsiveness to a Kinesin-5 inhibitor in colon cancer cell lines?
Conclusion
The study found that overexpression of genes on chromosome 20q is linked to resistance against the Kinesin-5 inhibitor.
Supporting Evidence
- Gene expression signatures were identified that predict responsiveness to a Kinesin-5 inhibitor.
- Chromosome 20q amplification was linked to resistance against the Kinesin-5 inhibitor.
- Disruption of AURKA, TPX2, and MYBL2 enhanced response to the Kinesin-5 inhibitor.
Takeaway
Some genes in colon cancer cells can make the cells resistant to a cancer drug, and if we block those genes, the drug might work better.
Methodology
The study used gene expression profiling and RNA interference to identify genes associated with resistance to a Kinesin-5 inhibitor in colon cancer cell lines.
Limitations
The study primarily focused on colon cancer cell lines, which may not fully represent all cancer types.
Participant Demographics
The study involved 26 colorectal cancer cell lines.
Statistical Information
P-Value
1.6e−3
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website